Rebamipide - an overview

rebamipide  BackgroundAims: The mucoprotective drug rebamipide is used to treat gastritis and peptic ulcers We compared the efficacy of MucostaR Conclusion: Rebamipide 300 mg three times daily provides the prevention for low-dose aspirin-induced gastric hemorrhage and erythema in healthy Helicobacter

In multivariate analysis, rebamipide was not inferior to PPI in preventing NSAID-induced serious GI complications   Rebamipide Rebamipide, is known to stimulate local prostaglandin synthesis and mucosal epithelial cell regeneration via an increase in the expression

Conclusion: Rebamipide 300 mg three times daily provides the prevention for low-dose aspirin-induced gastric hemorrhage and erythema in healthy Rebamipide is a gastroprotective agent with promising results against gastric damage induced by non-steroidal anti-inflammatory drugs